PORTON DOWN, England -
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today successful independent testing for bovine viral diarrhoea (BVD) by the Veterinary Laboratories Agency to evaluate the performance of the Enigma FL (Field Laboratory).
BVD is considered to be one of the main threats to cattle (1), affecting the majority of herds in the UK. It is closely related to classical swine fever virus, a serious disease of pigs, and to border disease virus, which infects sheep.
The Enigma FL instrument was used to analyse more than 100 blood samples that had already been screened by antigen ELISA and a laboratory-based RT-PCR for the presence of the BVD virus. Approximately half of the samples were proved BVDV positive by the laboratory-based PCR. With the level of concordance between the two tests being above 97%, this confirmed the Enigma FL system can produce laboratory-standard results with a high degree of confidence.
The Enigma FL has been designed for easy operation. Tests are provided in a single-use cartridge that can be stored at room temperature. The Enigma FL provides a PCR result in less than one hour, a timescale needed to allow field-based & pen-side diagnosis. On-site testing removes delays from transport of samples to the laboratory, which can often take days. The system requires minimal training and its utility for “pen-side” testing for BVD has already been demonstrated.
John McKinley, Chairman and CEO of Enigma, stated: “The Enigma Diagnostics tests could be deployed for the related viral diseases, such as classical swine fever, with minor modifications. The system itself is broadly applicable to many other veterinary pathogens, such as TB in cattle, bacterial infections and other viral infections, such as foot and mouth disease and avian influenza. Allowing vets to use advanced molecular diagnosis in the field will enhance their efficiency in managing endemic and exotic disease outbreaks identifying diseased animals and as importantly, non-infected ones and improve their surveillance capability.”
(1) www.rvc.ac.uk/BVD/documents/BVD_Disease.ppt Contacts UK Contact: Enigma Diagnostics Deborah Cordingley deborah.cordingley@enigmadiagnostics.com +44-1980-590131 US Contact: Richard Lewis Communications, Inc. +1-212-827-0020 Gregory Tiberend - Media gtiberend@rlcinc.com Cecelia Heer - Investors cheer@rlcinc.com
About Enigma Diagnostics Limited
Enigma Diagnostics Limited is a private UK based company specialising in developing the next generation of rapid molecular diagnostic instrument platforms for decentralised and point-of-care settings.
Enigma’s innovative and proprietary technology combines the speed and sensitivity of real-time PCR (polymerase chain reaction) with the simplicity needed for field-based, decentralised and point-of-care tests providing results from a raw sample in less than 45 minutes.
The Company is targeting a number of multi-billion pound markets, core among which are the Clinical and high value Applied Markets. Enigma’s commercialisation strategy is to maximise revenues from a continuous flow of market leading rapid diagnostic point-of care and in-field instrument and assay platforms, derived from its broad Intellectual Property portfolio of issued and filed patents. Enigma will partner with market leaders where global penetration of markets is required and where appropriate will build an in-house sales and marketing capability to direct distribution of its products.
Enigma has an exclusive licence from the Defence Science and Technology Laboratory to a portfolio of patents, which represent over 15 years of UK Ministry of Defence funded research and has licences from Applied Biosystems and Celera Licences for the commercialisation of real-time PCR instruments. Enigma’s R&D activities have generated a portfolio of over 50 plus worldwide patent families dedicated to real-time PCR and wider molecular technologies. Many of these patents are granted across a range of core commercial territories including US, EU and Japan with more extensive filing and grants across a number of other key territories.
For more information visit www.enigmadiagnostics.com.
Source: Enigma Diagnostics Limited
UK Contact: Deborah Cordingley, +44-1980-590131, or deborah.cordingley at enigmadiagnostics.com of Enigma Diagnostics; US Contact: Gregory Tiberend - Media, gtiberend at rlcinc.com, or Cecelia Heer - Investors, cheer at rlcinc.com, both of Richard Lewis Communications, Inc., +1-212-827-0020, for Enigma Diagnostics
Related Press Releases
Drink-Drive Cambridgeshire Vet Warned as to Future ConductSeptember 20th, 2009 LONDON - Following a two-year postponed judgment, the Disciplinary Committee (DC) of the Royal College of Veterinary Surgeons last week [17 September 2009] warned a Cambridgeshire veterinary surgeon as to his future conduct, after he had been convicted in 2006 for causing death by careless driving whilst under the influence of alcohol. In September 2007, the Committee heard that Peter Hanlon MRCVS, of Soham in Cambridgeshire, had been involved in a road traffic accident in February 2006.
Forest Laboratories UK Ltd Submits Marketing Authorisation Application for the First Dry Powder Inhalation Antibiotic for Cystic Fibrosis PatientsSeptember 14th, 2009 LONDON - Forest Laboratories UK Ltd, (a wholly owned subsidiary of Forest Laboratories Inc) announced that following the successful completion of its pan-European multi-centre phase III study (the Freedom Study), it has applied to the European Medicines Evaluation Agency (EMEA) to licence its new formulation dry powder colistimethate sodium for inhalation (Colobreathe(R)) for use by Cystic Fibrosis patients. The new formulation which was wholly developed by Forest Laboratories UK has previously been granted orphan drug status by the European Medicines Evaluation Agency (EMEA) and when approved Colobreathe(R) will be made available throughout the EU in conjunction with its chosen partner Grünenthal GmbH.
County Durham Vet Suspended for Practising While not RegisteredSeptember 10th, 2009 LONDON - The Disciplinary Committee (DC) of the Royal College of Veterinary Surgeons has suspended a veterinary surgeon for a period of three months for practising veterinary surgery while not registered with the College. At a hearing which concluded on 9 September, Silke Birgitt Lindridge, of the Consett Veterinary Centre, Medomsley Road, Consett, County Durham, was found guilty of disgraceful conduct in a professional respect for practising when she ought to have known that her name had been removed from the RCVS Register for non-payment of fees.
Disciplinary Judgment Postponed on Restoration ApplicationJuly 23rd, 2009 LONDON - The Disciplinary Committee of the Royal College of Veterinary Surgeons last week [17 July 2009] postponed its decision on whether to restore a former RCVS member to the Register, having previously struck her off for being unfit to practise. Miss Judith Kay, of Cambridge Road, Sawbridgeworth, Herts, was removed from the Register in January 2007 following her multiple convictions for drink-driving offences, driving disqualification and four-month imprisonment.
Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.July 15th, 2009 PORTON DOWN, England -
Enigma Diagnostics Limited, the decentralized and point-of-care molecular diagnostics company, announced today that it has signed two patent license agreements with Roche Molecular Systems, Inc. (RMS). The licenses signed on 15 July 2009, provide Enigma full access under patents owned or licensed by RMS and its affiliates to practice HybProbe real-time PCR chemistry and melt analysis and will allow Enigma to commercialize HybProbe PCR tests for human and veterinary in vitro diagnostics on a worldwide basis.
/C O R R E C T I O N -- Enigma Diagnostics Limited/June 29th, 2009 PORTON DOWN, England - In the news release, "Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK's Veterinary Laboratories Agency" issued on 30 Jun 2009 13:17 GMT, by Enigma Diagnostics Limited over PR Newswire, we are advised by a representative of the company that a second footnote has been added at the end of the fourth paragraph. The note references the following link: enigmadiagnostics.com/template2.php?page=news.php&m=4
Complete, corrected release follows:
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today successful independent testing for bovine viral diarrhoea (BVD) by the Veterinary Laboratories Agency to evaluate the performance of the Enigma FL (Field Laboratory).
Enigma Diagnostics Announces Patent On Real-Time Monitoring of Amplification Reactions Upheld In Entirety Following Opposition From BD at European Patent OfficeJune 15th, 2009 PORTON DOWN, England - Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today it was issued European Patent EP1044283, which covers the use of endonuclease-based reporting in PCR and other nucleic acid amplification technologies. Becton, Dickinson and Company (BD) had filed a claim in opposition to this patent which was rejected by the European Patent Office at a proceeding in Munich on May 28.
Copan and POCARED Diagnostics Partner to Enhance the Use of Liquid Based Microbiology and Introduce the Next Generation Microbiology SystemsMay 17th, 2009 BRESCIA, Italy - Alliance Aims to Develop Powerful Tools for Accurate and Rapid Microbiology Testing Leading to Improved Patient Outcomes
Under the partnership, the two companies will enhance the use of liquid based microbiology diagnostic products that incorporate Copan innovative collection and transport devices (like ESwab) for use in combination with POCARED's real-time quantification and identification platform. The Copan and POCARED partnership will also introduce a new level of automation and ease of use.
Mycosafe and ViruSure: Two Austrian Biosafety Companies Expand to AsiaMarch 18th, 2009 VIENNA, Austria and SINGAPORE - Mycoplasma biosafety specialist Mycosafe Diagnostics GmbH and virus and
prion biosafety company ViruSure GmbH - both based in Vienna, Austria - today
announced at BioMedical Asia 2009 that they are to establish a second site in
Singapore as part of a joint venture. This move will ensure that both
companies are in an ideal position to offer the biosafety expertise and
laboratory services so urgently required in the rapidly-expanding
biopharmaceutical and biotechnology industry in Asia.
ITV 'Pets Undercover': RCVS ResponseMarch 16th, 2009 LONDON - "The main message that pet owners and veterinary surgeons should take
home from this evening's Tonight programme is the importance of communicating
with each other."
So says RCVS President Jill Nute after watching ITV Tonight presenter
Jonathan Maitland's report - 'Pets undercover' - on the types of treatment
and level of veterinary fees charged by some members of the veterinary
profession. "There is no National Health Service for animals.
Related News
UAE lifts ban on cattle importsAugust 21st, 2009 DUBAI - The United Arab Emirates (UAE) has lifted a ban on cattle imports from Somalia, the WAM news agency reported Friday citing the environment ministry. Cattle imports from the two Somali cities of Bosaso and Barabara will now be allowed in the country, UAE Environment and Water Minister Rashid Ahmed Bin Fahad said Thursday.
Century-old enigma of prehistoric marine mass grave solvedJune 9th, 2009 WASHINGTON - A new study has solved a century-old enigma of the origin of a prehistoric marine massive bonebed in southern California, US. The study was led by Nick Pyenson, a post-doctoral fellow in the UBC (University of British Columbia) Department of Zoology.
Continucare says it bought sleep study testing facility operator for an undisclosed amountAugust 13th, 2009 Continucare buys Professional Sleep DiagnosticsMIAMI — Continucare Corp. said Thursday it bought Professional Sleep Diagnostics Inc., a company that operates 13 sleep diagnostic centers, for an undisclosed amount.
Diagnostics product maker Qiagen NV announces offering of new common sharesSeptember 22nd, 2009 Qiagen NV announces offering of new common sharesNetherlands-based diagnostic products maker Qiagen NV announced on Tuesday a placement of 27.5 million newly issued common shares in an international offering. Shares will be offered to institutional investors outside the United States and as a registered offering in the United States, the company said in a statement.
British govt apologizes for 'inhumane' treatment of gay code-breaker Alan TuringSeptember 11th, 2009 LONDON — British Prime Minister Gordon Brown has apologized for the "inhumane" treatment of World War II code-breaker Alan Turing. The mathematician helped crack Nazi Germany's Enigma encryption machine — a turning point in the war — and is considered a father of modern computing.
Veterinary association to go ahead with fish toss team-building event at Seattle conferenceJune 13th, 2009 Fish toss a go for veterinarians visiting SeattleSEATTLE — Despite complaints from an animal-rights group, a national veterinary association says Seattle's famed fishmongers will be tossing dead fish at its Seattle convention next month. American Veterinary Medical Association CEO Ron DeHaven says his organization will proceed with a plan to host a team-building program offered by the famous fish-throwers of Seattle's Pike Place Fish Market.
VCA Antech buys Eklin Medical Systems for undisclosed amount in technology expansionJuly 1st, 2009 VCA Antech buys Eklin for undisclosed amountLOS ANGELES — Veterinary services provider VCA Antech Inc. said Wednesday it bought Eklin Medical Systems Inc.
Castro praises Obama's `courageous' stand on climate changeSeptember 24th, 2009 HAVANA - Cuban leader Fidel Castro has praised US President Barack Obama for taking a "courageous" stand on climate change, but added it was not right that Obama tried to make people believe that humanity could survive under the laws of capitalism. Castro wrote in a commentary, titled "El Obama serio" (The Serious Obama) and published by state media Wednesday, that the US president's address at the UN Tuesday was a "courageous gesture" that showed his concern about climate change.
Utah judge orders man charged with threatening Obama to get psychiatric evaluationJune 18th, 2009 Evaluation ordered for man accused of Obama threatSALT LAKE CITY — A psychiatric evaluation has been ordered for a man accused of telling bank employees in Utah he was "on a mission to kill" President Barack Obama. Federal Magistrate Robert T.
'The Lark Ascending' named UK's Favourite Classical MusicApril 14th, 2009 LONDON - 'The Lark Ascending' by Ralph Vaughan Williams has maintained its top spot as the Britain's favourite piece of classical music for the third year running. In the poll conducted by Classic FM, soaring violin and orchestra piece was voted the best piece of classical music followed by his 'Fantasia' on a Theme of Thomas Tallis at the second place.
